Eleven healthy volunteers completed a study to compare the relative bioavailability to orally administered ciramadol in a fasting versus postprandial state. A single oral dose of 30mg of ciramadol was administered on two separate occasions, 2 weeks apart, in a randomized crossover study. A mono-or b
The effect of salbutamol on mood in normal subjects
✍ Scribed by Dr David B. Menkes; J. Paul Fawcett; Megan R. Nunn; David Boothman-Burrell
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 353 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The beta‐2‐adrenoceptor agonist salbutamol, widely used in the treatment of asthma, is thought to have antidepressant activity and possibly an abuse liability. In order to examine the mood‐altering potential of this drug, a placebocontrolled, double‐blind crossover trial was conducted in 21 psychiatrically normal subjects. The Profile of Mood States (POMS) was used to assess mood at baseline, after six weeks of placebo and salbutamol treatment (in either order), and after a four‐week washout period in between treatments. The results showed little difference between treatments, apart from a tendency for salbutamol to worsen subjective mood relative to placebo during the first treatment phase only. In conclusion, the blinded, placebo‐controlled administration of salbutamol gives no evidence of mood‐elevating or addictive properties in psychiatrically normal individuals.
📜 SIMILAR VOLUMES
## Abstract There is evidence from human and animal studies that substance P (SP) is involved in the etiopathology of depression and anxiety. Furthermore, animal studies have shown effects of SP on memory. In a double‐blind, randomized cross‐over study, 13 healthy young men received SP (1.5 pmol/kg